feedback - Sales Representative Viatris Employee Review

4.0
Nov 29, 2020
Recommend
CEO approval
Business Outlook

Pros

Small Pharma with big Pharma mentality

Cons

Limited Branded products and no current pipeline

avatar
Viatris Response
5y
Thanks for your feedback. Now that Mylan and Upjohn have combined to form Viatris, we have a global portfolio of more than 1,400 molecules across a broad range of major therapeutic areas, including best-in-class, iconic brand-name products, as well as global key brands, generics, including branded and complex generics, biosimilars and over-the-counter offerings. We are uniquely positioned to help meet the world’s evolving healthcare needs, and it’s rewarding to be part of a team that is able to make a difference!

Explore other reviews about Viatris

5.0
Feb 25, 2026
Recommend
CEO approval
Business Outlook

Pros

Great people and the having this kind of experience on your resume is a plus. You often get opportuinites to make impressions on higher management from other teams/divisions.

Cons

There aren't too many that stick out which would lead me not to recommend this role.

1.0
Jun 3, 2026
Recommend
CEO approval
Business Outlook

Pros

•it pays, but not a serious company. •no new data in 5-10 years, Viatris is a Pfizer pet project went wrong.

Cons

•New England respiratory was an unmitigated disaster. •Very little competent management , the company doesn’t seem interested in succeeding.

See reviews by: Helpful|Rating|Date|All